Dr. Egon Jonsson
Executive Director & CEO
Egon is a health economist and the former head of the SBU--the Swedish Agency on Health Technology Assessment. He went on to join the WHO, where he helped establish the Organization's Health Evidence Network, a group that includes the IHE.
“Antimicrobial resistant organisms” (AROs) refers to bacteria capable of causing human disease that are resistant to one or more classes of currently available antibiotics. This resistance is associated with treatment failure leading to significant disease, infection complications, prolonged hospital stay, and increased risk of death. In the United States, it is estimated that each year at least 2 million people acquire serious infections caused by AROs, and at least 23,000 people die annually as a direct result of these infections. Of particular concern in Canadian hospitals are AROs such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and multidrug-resistant Gram-negative bacteria, especially those with extended-spectrum β-lactamase (ESBL), and carbapenem-resistant Enterobacteriaceae (CRE). Active surveillance screening for MRSA, VRE, and ESBL is receiving greater attention for its potential value in identifying carriers of these pathogens to prevent further transmission. The report is an evidence summary describing the state of evidence with respect to screening for AROs.
Economic Evaluation of Complex Health System Interventions: A Discussion Paper has been produced in response to a request from and in partnership with CIHR Institute of Health Services and Policy Research (CIHR IHSPR). The discussion paper provides guidance to those tasked with conducting an economic evaluation of complex health system interventions. The guidance will be an elaboration of existing National guidelines for economic evaluation and serve as a discussion paper to aid investigators conducting economic evaluations of complex health interventions. This paper is intended to be a starting point for heatlh system and policy researchers who wish to understand some of the fundamentals of economic evaluation and its application complex interventions.
This guide has been developed by the information specialists at the Institute of Health Economics in Edmonton Alberta and is intended to facilitate searching for health technology assessments (HTAs) or systematic reviews by providing the list of current and reliable internet-based resources that we regularly use in our work. We have tried as much as possible to match this guide to our search process. While the particular sources we search depend on their relevance to the topic at hand, this is the master list of resources from which we select when designing a search.
IHE In Your Pocket was designed to provide a compact, comprehensive, and comparative overview of the economic aspects of the Canadian health care system. It has been revised every second year since 2006.
As in the earlier editions, we have adopted a broad, population health approach. We have substantially reorganized the 2014 edition. We divided data on the health care system into components. For each component, we provide the most important economic indicators which reflect capacity, investment, utilization, prices and costs, total expenditures and finance, on the supply side; and population characteristics, population behaviour, finance and indirect costs on the demand side.